Severe lophomoniasis in a patient with diabetes and past history of COVID-19 in Central Iran: case report.

Autor: Mirbadie SR; School of Medicine, Shahroud University of Medical Sciences, Bahar Hospital, Shahroud, Iran., Taheri A; Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis, Mazandaran University of Medical Sciences, Farah-Abad Road, Sari, Iran., Roshanzamir E; School of Medicine, Shahroud University of Medical Sciences, Bahar Hospital, Shahroud, Iran., Soleymani E; Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis, Mazandaran University of Medical Sciences, Farah-Abad Road, Sari, Iran., Fakhar M; Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis, Mazandaran University of Medical Sciences, Farah-Abad Road, Sari, Iran.
Jazyk: angličtina
Zdroj: The Journal of international medical research [J Int Med Res] 2024 Feb; Vol. 52 (2), pp. 3000605241232917.
DOI: 10.1177/03000605241232917
Abstrakt: In this case report, we address the diagnostic challenges and clinical implications of severe infection with Lophomonas blattarum in a patient initially suspected of experiencing long COVID symptoms. We describe the patient's medical history, initial symptoms, diagnostic tests, and treatment. A female patient with diabetes in her early 60s presented with severe shortness of breath and was initially diagnosed with diabetic ketoacidosis (DKA). After resolution of her DKA symptoms, persistent respiratory issues led to a COVID-19 test, which was negative. A chest computed tomography scan revealed abnormalities, prompting bronchoscopy and bronchoalveolar lavage fluid analysis, which confirmed the presence of L. blattarum . Notably, the protozoan remained mobile and viable even after a 4-day transport at ambient temperature. This case emphasizes the importance of considering alternative diagnoses and improving awareness about L. blattarum infection in patients with respiratory symptoms, for timely and accurate management.
Competing Interests: Declaration of conflicting interestThe authors declare that there is no conflict of interest.
Databáze: MEDLINE